This report aims to provide a comprehensive presentation of the global market for Bladder Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bladder Cancer. This report contains market size and forecasts of Bladder Cancer in global, including the following market information:
Global Bladder Cancer Market Revenue, 2019-2024, 2024-2029, ($ millions)
Global top five companies in 2023 (%)
The global Bladder Cancer market was valued at US$ million in 2023 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Intravesical therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Bladder Cancer include Bristol-Myers Squibb, Eli Lilly, F. Hoffman-La Roche, Pfizer, Accord Healthcare, AstraZeneca, Bedford Lab, Merck and Sanofi, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bladder Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bladder Cancer Market, by Type, 2019-2024, 2024-2029 ($ millions)
Global Bladder Cancer Market Segment Percentages, by Type, 2023 (%)
Intravesical therapy
Chemotherapy
Preservation therapy
Global Bladder Cancer Market, by Application, 2019-2024, 2024-2029 ($ millions)
Global Bladder Cancer Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Global Bladder Cancer Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions)
Global Bladder Cancer Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bladder Cancer revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Bladder Cancer revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Eli Lilly
F. Hoffman-La Roche
Pfizer
Accord Healthcare
AstraZeneca
Bedford Lab
Merck
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bladder Cancer, market overview.
Chapter 2: Global Bladder Cancer market size in revenue.
Chapter 3: Detailed analysis of Bladder Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bladder Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Bladder Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bladder Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bladder Cancer Overall Market Size
2.1 Global Bladder Cancer Market Size: 2022 VS 2031
2.2 Global Bladder Cancer Market Size, Prospects & Forecasts: 2019-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bladder Cancer Players in Global Market
3.2 Top Global Bladder Cancer Companies Ranked by Revenue
3.3 Global Bladder Cancer Revenue by Companies
3.4 Top 3 and Top 5 Bladder Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Bladder Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bladder Cancer Players in Global Market
3.6.1 List of Global Tier 1 Bladder Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Bladder Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Bladder Cancer Market Size Markets, 2022 & 2031
4.1.2 Intravesical therapy
4.1.3 Chemotherapy
4.1.4 Preservation therapy
4.2 By Type - Global Bladder Cancer Revenue & Forecasts
4.2.1 By Type - Global Bladder Cancer Revenue, 2019-2024
4.2.2 By Type - Global Bladder Cancer Revenue, 2024-2031
4.2.3 By Type - Global Bladder Cancer Revenue Market Share, 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bladder Cancer Market Size, 2022 & 2031
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Bladder Cancer Revenue & Forecasts
5.2.1 By Application - Global Bladder Cancer Revenue, 2019-2024
5.2.2 By Application - Global Bladder Cancer Revenue, 2024-2031
5.2.3 By Application - Global Bladder Cancer Revenue Market Share, 2019-2031
6 Sights by Region
6.1 By Region - Global Bladder Cancer Market Size, 2022 & 2031
6.2 By Region - Global Bladder Cancer Revenue & Forecasts
6.2.1 By Region - Global Bladder Cancer Revenue, 2019-2024
6.2.2 By Region - Global Bladder Cancer Revenue, 2024-2031
6.2.3 By Region - Global Bladder Cancer Revenue Market Share, 2019-2031
6.3 North America
6.3.1 By Country - North America Bladder Cancer Revenue, 2019-2031
6.3.2 US Bladder Cancer Market Size, 2019-2031
6.3.3 Canada Bladder Cancer Market Size, 2019-2031
6.3.4 Mexico Bladder Cancer Market Size, 2019-2031
6.4 Europe
6.4.1 By Country - Europe Bladder Cancer Revenue, 2019-2031
6.4.2 Germany Bladder Cancer Market Size, 2019-2031
6.4.3 France Bladder Cancer Market Size, 2019-2031
6.4.4 U.K. Bladder Cancer Market Size, 2019-2031
6.4.5 Italy Bladder Cancer Market Size, 2019-2031
6.4.6 Russia Bladder Cancer Market Size, 2019-2031
6.4.7 Nordic Countries Bladder Cancer Market Size, 2019-2031
6.4.8 Benelux Bladder Cancer Market Size, 2019-2031
6.5 Asia
6.5.1 By Region - Asia Bladder Cancer Revenue, 2019-2031
6.5.2 China Bladder Cancer Market Size, 2019-2031
6.5.3 Japan Bladder Cancer Market Size, 2019-2031
6.5.4 South Korea Bladder Cancer Market Size, 2019-2031
6.5.5 Southeast Asia Bladder Cancer Market Size, 2019-2031
6.5.6 India Bladder Cancer Market Size, 2019-2031
6.6 South America
6.6.1 By Country - South America Bladder Cancer Revenue, 2019-2031
6.6.2 Brazil Bladder Cancer Market Size, 2019-2031
6.6.3 Argentina Bladder Cancer Market Size, 2019-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Bladder Cancer Revenue, 2019-2031
6.7.2 Turkey Bladder Cancer Market Size, 2019-2031
6.7.3 Israel Bladder Cancer Market Size, 2019-2031
6.7.4 Saudi Arabia Bladder Cancer Market Size, 2019-2031
6.7.5 UAE Bladder Cancer Market Size, 2019-2031
7 Bladder Cancer Companies Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Bladder Cancer Major Product Offerings
7.1.4 Bristol-Myers Squibb Bladder Cancer Revenue in Global Market (2019-2024)
7.1.5 Bristol-Myers Squibb Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Bladder Cancer Major Product Offerings
7.2.4 Eli Lilly Bladder Cancer Revenue in Global Market (2019-2024)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 F. Hoffman-La Roche
7.3.1 F. Hoffman-La Roche Company Summary
7.3.2 F. Hoffman-La Roche Business Overview
7.3.3 F. Hoffman-La Roche Bladder Cancer Major Product Offerings
7.3.4 F. Hoffman-La Roche Bladder Cancer Revenue in Global Market (2019-2024)
7.3.5 F. Hoffman-La Roche Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Bladder Cancer Major Product Offerings
7.4.4 Pfizer Bladder Cancer Revenue in Global Market (2019-2024)
7.4.5 Pfizer Key News & Latest Developments
7.5 Accord Healthcare
7.5.1 Accord Healthcare Company Summary
7.5.2 Accord Healthcare Business Overview
7.5.3 Accord Healthcare Bladder Cancer Major Product Offerings
7.5.4 Accord Healthcare Bladder Cancer Revenue in Global Market (2019-2024)
7.5.5 Accord Healthcare Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Bladder Cancer Major Product Offerings
7.6.4 AstraZeneca Bladder Cancer Revenue in Global Market (2019-2024)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Bedford Lab
7.7.1 Bedford Lab Company Summary
7.7.2 Bedford Lab Business Overview
7.7.3 Bedford Lab Bladder Cancer Major Product Offerings
7.7.4 Bedford Lab Bladder Cancer Revenue in Global Market (2019-2024)
7.7.5 Bedford Lab Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Bladder Cancer Major Product Offerings
7.8.4 Merck Bladder Cancer Revenue in Global Market (2019-2024)
7.8.5 Merck Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Bladder Cancer Major Product Offerings
7.9.4 Sanofi Bladder Cancer Revenue in Global Market (2019-2024)
7.9.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Bladder Cancer Market Opportunities & Trends in Global Market
Table 2. Bladder Cancer Market Drivers in Global Market
Table 3. Bladder Cancer Market Restraints in Global Market
Table 4. Key Players of Bladder Cancer in Global Market
Table 5. Top Bladder Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Bladder Cancer Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Bladder Cancer Revenue Share by Companies, 2019-2024
Table 8. Global Companies Bladder Cancer Product Type
Table 9. List of Global Tier 1 Bladder Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bladder Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Bladder Cancer Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Bladder Cancer Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Bladder Cancer Revenue in Global (US$, Mn), 2024-2031
Table 14. By Application ? Global Bladder Cancer Revenue, (US$, Mn), 2022 & 2031
Table 15. By Application - Bladder Cancer Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Bladder Cancer Revenue in Global (US$, Mn), 2024-2031
Table 17. By Region ? Global Bladder Cancer Revenue, (US$, Mn), 2022 & 2031
Table 18. By Region - Global Bladder Cancer Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Bladder Cancer Revenue (US$, Mn), 2024-2031
Table 20. By Country - North America Bladder Cancer Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Bladder Cancer Revenue, (US$, Mn), 2024-2031
Table 22. By Country - Europe Bladder Cancer Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Bladder Cancer Revenue, (US$, Mn), 2024-2031
Table 24. By Region - Asia Bladder Cancer Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Bladder Cancer Revenue, (US$, Mn), 2024-2031
Table 26. By Country - South America Bladder Cancer Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Bladder Cancer Revenue, (US$, Mn), 2024-2031
Table 28. By Country - Middle East & Africa Bladder Cancer Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Bladder Cancer Revenue, (US$, Mn), 2024-2031
Table 30. Bristol-Myers Squibb Company Summary
Table 31. Bristol-Myers Squibb Bladder Cancer Product Offerings
Table 32. Bristol-Myers Squibb Bladder Cancer Revenue (US$, Mn) & (2019-2024)
Table 33. Bristol-Myers Squibb Key News & Latest Developments
Table 34. Eli Lilly Company Summary
Table 35. Eli Lilly Bladder Cancer Product Offerings
Table 36. Eli Lilly Bladder Cancer Revenue (US$, Mn) & (2019-2024)
Table 37. Eli Lilly Key News & Latest Developments
Table 38. F. Hoffman-La Roche Company Summary
Table 39. F. Hoffman-La Roche Bladder Cancer Product Offerings
Table 40. F. Hoffman-La Roche Bladder Cancer Revenue (US$, Mn) & (2019-2024)
Table 41. F. Hoffman-La Roche Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Bladder Cancer Product Offerings
Table 44. Pfizer Bladder Cancer Revenue (US$, Mn) & (2019-2024)
Table 45. Pfizer Key News & Latest Developments
Table 46. Accord Healthcare Company Summary
Table 47. Accord Healthcare Bladder Cancer Product Offerings
Table 48. Accord Healthcare Bladder Cancer Revenue (US$, Mn) & (2019-2024)
Table 49. Accord Healthcare Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Bladder Cancer Product Offerings
Table 52. AstraZeneca Bladder Cancer Revenue (US$, Mn) & (2019-2024)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Bedford Lab Company Summary
Table 55. Bedford Lab Bladder Cancer Product Offerings
Table 56. Bedford Lab Bladder Cancer Revenue (US$, Mn) & (2019-2024)
Table 57. Bedford Lab Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Bladder Cancer Product Offerings
Table 60. Merck Bladder Cancer Revenue (US$, Mn) & (2019-2024)
Table 61. Merck Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Bladder Cancer Product Offerings
Table 64. Sanofi Bladder Cancer Revenue (US$, Mn) & (2019-2024)
Table 65. Sanofi Key News & Latest Developments
List of Figures
Figure 1. Bladder Cancer Segment by Type in 2022
Figure 2. Bladder Cancer Segment by Application in 2022
Figure 3. Global Bladder Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Bladder Cancer Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Bladder Cancer Revenue, 2019-2031 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bladder Cancer Revenue in 2022
Figure 8. By Type - Global Bladder Cancer Revenue Market Share, 2019-2031
Figure 9. By Application - Global Bladder Cancer Revenue Market Share, 2019-2031
Figure 10. By Type - Global Bladder Cancer Revenue, (US$, Mn), 2022 & 2031
Figure 11. By Type - Global Bladder Cancer Revenue Market Share, 2019-2031
Figure 12. By Application - Global Bladder Cancer Revenue, (US$, Mn), 2022 & 2031
Figure 13. By Application - Global Bladder Cancer Revenue Market Share, 2019-2031
Figure 14. By Region - Global Bladder Cancer Revenue Market Share, 2019-2031
Figure 15. By Country - North America Bladder Cancer Revenue Market Share, 2019-2031
Figure 16. US Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 17. Canada Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 18. Mexico Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 19. By Country - Europe Bladder Cancer Revenue Market Share, 2019-2031
Figure 20. Germany Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 21. France Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 22. U.K. Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 23. Italy Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 24. Russia Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 25. Nordic Countries Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 26. Benelux Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 27. By Region - Asia Bladder Cancer Revenue Market Share, 2019-2031
Figure 28. China Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 29. Japan Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 30. South Korea Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 31. Southeast Asia Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 32. India Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 33. By Country - South America Bladder Cancer Revenue Market Share, 2019-2031
Figure 34. Brazil Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 35. Argentina Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 36. By Country - Middle East & Africa Bladder Cancer Revenue Market Share, 2019-2031
Figure 37. Turkey Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 38. Israel Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 39. Saudi Arabia Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 40. UAE Bladder Cancer Revenue, (US$, Mn), 2019-2031
Figure 41. Bristol-Myers Squibb Bladder Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Eli Lilly Bladder Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. F. Hoffman-La Roche Bladder Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Pfizer Bladder Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Accord Healthcare Bladder Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. AstraZeneca Bladder Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Bedford Lab Bladder Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Merck Bladder Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Sanofi Bladder Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
